nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP2C8—Ifosfamide—testicular cancer	0.119	0.146	CbGbCtD
Loratadine—CYP2C19—Ifosfamide—testicular cancer	0.0997	0.122	CbGbCtD
Loratadine—CYP2C9—Ifosfamide—testicular cancer	0.0829	0.102	CbGbCtD
Loratadine—ABCB1—Dactinomycin—testicular cancer	0.0681	0.0835	CbGbCtD
Loratadine—CYP2C8—Etoposide—testicular cancer	0.0568	0.0696	CbGbCtD
Loratadine—CYP3A4—Ifosfamide—testicular cancer	0.0482	0.0591	CbGbCtD
Loratadine—ABCB1—Vinblastine—testicular cancer	0.0427	0.0523	CbGbCtD
Loratadine—CYP2C9—Cisplatin—testicular cancer	0.0403	0.0494	CbGbCtD
Loratadine—CYP2D6—Vinblastine—testicular cancer	0.0402	0.0493	CbGbCtD
Loratadine—ABCB1—Cisplatin—testicular cancer	0.0391	0.048	CbGbCtD
Loratadine—ABCB1—Etoposide—testicular cancer	0.0385	0.0471	CbGbCtD
Loratadine—ABCB1—Doxorubicin—testicular cancer	0.0262	0.0321	CbGbCtD
Loratadine—CYP3A4—Vinblastine—testicular cancer	0.0256	0.0313	CbGbCtD
Loratadine—ABCB1—Methotrexate—testicular cancer	0.0254	0.0311	CbGbCtD
Loratadine—CYP2D6—Doxorubicin—testicular cancer	0.0247	0.0303	CbGbCtD
Loratadine—CYP3A4—Etoposide—testicular cancer	0.023	0.0282	CbGbCtD
Loratadine—CYP3A4—Doxorubicin—testicular cancer	0.0157	0.0193	CbGbCtD
Loratadine—Feeling abnormal—Bleomycin—testicular cancer	0.000669	0.00364	CcSEcCtD
Loratadine—Vomiting—Chlorambucil—testicular cancer	0.000667	0.00363	CcSEcCtD
Loratadine—Increased appetite—Epirubicin—testicular cancer	0.000665	0.00362	CcSEcCtD
Loratadine—Malaise—Cisplatin—testicular cancer	0.000661	0.00359	CcSEcCtD
Loratadine—Diarrhoea—Vinblastine—testicular cancer	0.000658	0.00358	CcSEcCtD
Loratadine—Dysgeusia—Etoposide—testicular cancer	0.000657	0.00358	CcSEcCtD
Loratadine—Dermatitis bullous—Epirubicin—testicular cancer	0.000654	0.00356	CcSEcCtD
Loratadine—Fatigue—Dactinomycin—testicular cancer	0.000653	0.00355	CcSEcCtD
Loratadine—Hypotension—Ifosfamide—testicular cancer	0.000648	0.00353	CcSEcCtD
Loratadine—Pain—Dactinomycin—testicular cancer	0.000647	0.00352	CcSEcCtD
Loratadine—Body temperature increased—Bleomycin—testicular cancer	0.000642	0.00349	CcSEcCtD
Loratadine—Lethargy—Epirubicin—testicular cancer	0.000638	0.00347	CcSEcCtD
Loratadine—Dizziness—Vinblastine—testicular cancer	0.000636	0.00346	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000632	0.00344	CcSEcCtD
Loratadine—Myalgia—Cisplatin—testicular cancer	0.000624	0.00339	CcSEcCtD
Loratadine—Feeling abnormal—Dactinomycin—testicular cancer	0.000624	0.00339	CcSEcCtD
Loratadine—Nausea—Chlorambucil—testicular cancer	0.000623	0.00339	CcSEcCtD
Loratadine—Paraesthesia—Ifosfamide—testicular cancer	0.000623	0.00339	CcSEcCtD
Loratadine—Ill-defined disorder—Etoposide—testicular cancer	0.000623	0.00339	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00062	0.00337	CcSEcCtD
Loratadine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000619	0.00337	CcSEcCtD
Loratadine—Somnolence—Ifosfamide—testicular cancer	0.000617	0.00335	CcSEcCtD
Loratadine—Discomfort—Cisplatin—testicular cancer	0.000616	0.00335	CcSEcCtD
Loratadine—Increased appetite—Doxorubicin—testicular cancer	0.000615	0.00335	CcSEcCtD
Loratadine—Vomiting—Vinblastine—testicular cancer	0.000611	0.00332	CcSEcCtD
Loratadine—Malaise—Etoposide—testicular cancer	0.000605	0.00329	CcSEcCtD
Loratadine—Dermatitis bullous—Doxorubicin—testicular cancer	0.000605	0.00329	CcSEcCtD
Loratadine—Headache—Vinblastine—testicular cancer	0.000602	0.00327	CcSEcCtD
Loratadine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000599	0.00326	CcSEcCtD
Loratadine—Body temperature increased—Dactinomycin—testicular cancer	0.000598	0.00326	CcSEcCtD
Loratadine—Abdominal pain—Dactinomycin—testicular cancer	0.000598	0.00326	CcSEcCtD
Loratadine—Fatigue—Ifosfamide—testicular cancer	0.000598	0.00325	CcSEcCtD
Loratadine—Anaphylactic shock—Cisplatin—testicular cancer	0.000598	0.00325	CcSEcCtD
Loratadine—Pain—Ifosfamide—testicular cancer	0.000593	0.00323	CcSEcCtD
Loratadine—Constipation—Ifosfamide—testicular cancer	0.000593	0.00323	CcSEcCtD
Loratadine—Loss of consciousness—Etoposide—testicular cancer	0.00059	0.00321	CcSEcCtD
Loratadine—Lethargy—Doxorubicin—testicular cancer	0.00059	0.00321	CcSEcCtD
Loratadine—Nervous system disorder—Cisplatin—testicular cancer	0.000586	0.00319	CcSEcCtD
Loratadine—Cough—Etoposide—testicular cancer	0.000586	0.00319	CcSEcCtD
Loratadine—Tachycardia—Cisplatin—testicular cancer	0.000584	0.00317	CcSEcCtD
Loratadine—Asthenia—Bleomycin—testicular cancer	0.000582	0.00317	CcSEcCtD
Loratadine—Skin disorder—Cisplatin—testicular cancer	0.000581	0.00316	CcSEcCtD
Loratadine—Hypertension—Etoposide—testicular cancer	0.00058	0.00315	CcSEcCtD
Loratadine—Feeling abnormal—Ifosfamide—testicular cancer	0.000572	0.00311	CcSEcCtD
Loratadine—Chest pain—Etoposide—testicular cancer	0.000572	0.00311	CcSEcCtD
Loratadine—Nausea—Vinblastine—testicular cancer	0.000571	0.00311	CcSEcCtD
Loratadine—Abdominal pain upper—Epirubicin—testicular cancer	0.000571	0.0031	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000568	0.00309	CcSEcCtD
Loratadine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000567	0.00309	CcSEcCtD
Loratadine—Discomfort—Etoposide—testicular cancer	0.000565	0.00307	CcSEcCtD
Loratadine—Hypotension—Cisplatin—testicular cancer	0.000559	0.00304	CcSEcCtD
Loratadine—Gastritis—Epirubicin—testicular cancer	0.000553	0.00301	CcSEcCtD
Loratadine—Abdominal pain—Ifosfamide—testicular cancer	0.000548	0.00298	CcSEcCtD
Loratadine—Body temperature increased—Ifosfamide—testicular cancer	0.000548	0.00298	CcSEcCtD
Loratadine—Anaphylactic shock—Etoposide—testicular cancer	0.000548	0.00298	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000545	0.00296	CcSEcCtD
Loratadine—Asthenia—Dactinomycin—testicular cancer	0.000543	0.00295	CcSEcCtD
Loratadine—Paraesthesia—Cisplatin—testicular cancer	0.000537	0.00292	CcSEcCtD
Loratadine—Tachycardia—Etoposide—testicular cancer	0.000535	0.00291	CcSEcCtD
Loratadine—Skin disorder—Etoposide—testicular cancer	0.000532	0.00289	CcSEcCtD
Loratadine—Abdominal pain upper—Doxorubicin—testicular cancer	0.000528	0.00287	CcSEcCtD
Loratadine—Diarrhoea—Dactinomycin—testicular cancer	0.000518	0.00282	CcSEcCtD
Loratadine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000516	0.00281	CcSEcCtD
Loratadine—Vomiting—Bleomycin—testicular cancer	0.000516	0.00281	CcSEcCtD
Loratadine—Drowsiness—Methotrexate—testicular cancer	0.000515	0.0028	CcSEcCtD
Loratadine—Depression—Methotrexate—testicular cancer	0.000513	0.00279	CcSEcCtD
Loratadine—Hypotension—Etoposide—testicular cancer	0.000512	0.00278	CcSEcCtD
Loratadine—Rash—Bleomycin—testicular cancer	0.000512	0.00278	CcSEcCtD
Loratadine—Gastritis—Doxorubicin—testicular cancer	0.000512	0.00278	CcSEcCtD
Loratadine—Pain—Cisplatin—testicular cancer	0.000511	0.00278	CcSEcCtD
Loratadine—Dermatitis—Bleomycin—testicular cancer	0.000511	0.00278	CcSEcCtD
Loratadine—Pollakiuria—Epirubicin—testicular cancer	0.000499	0.00271	CcSEcCtD
Loratadine—Asthenia—Ifosfamide—testicular cancer	0.000498	0.00271	CcSEcCtD
Loratadine—Feeling abnormal—Cisplatin—testicular cancer	0.000493	0.00268	CcSEcCtD
Loratadine—Paraesthesia—Etoposide—testicular cancer	0.000492	0.00268	CcSEcCtD
Loratadine—Somnolence—Etoposide—testicular cancer	0.000487	0.00265	CcSEcCtD
Loratadine—Hepatobiliary disease—Methotrexate—testicular cancer	0.000487	0.00265	CcSEcCtD
Loratadine—Epistaxis—Methotrexate—testicular cancer	0.000485	0.00264	CcSEcCtD
Loratadine—Nausea—Bleomycin—testicular cancer	0.000482	0.00262	CcSEcCtD
Loratadine—Drowsiness—Epirubicin—testicular cancer	0.000482	0.00262	CcSEcCtD
Loratadine—Vomiting—Dactinomycin—testicular cancer	0.000481	0.00262	CcSEcCtD
Loratadine—Rash—Dactinomycin—testicular cancer	0.000477	0.0026	CcSEcCtD
Loratadine—Diarrhoea—Ifosfamide—testicular cancer	0.000475	0.00258	CcSEcCtD
Loratadine—Gastrointestinal disorder—Etoposide—testicular cancer	0.000473	0.00257	CcSEcCtD
Loratadine—Body temperature increased—Cisplatin—testicular cancer	0.000473	0.00257	CcSEcCtD
Loratadine—Fatigue—Etoposide—testicular cancer	0.000472	0.00257	CcSEcCtD
Loratadine—Constipation—Etoposide—testicular cancer	0.000469	0.00255	CcSEcCtD
Loratadine—Pain—Etoposide—testicular cancer	0.000469	0.00255	CcSEcCtD
Loratadine—Pollakiuria—Doxorubicin—testicular cancer	0.000462	0.00251	CcSEcCtD
Loratadine—Dizziness—Ifosfamide—testicular cancer	0.000459	0.0025	CcSEcCtD
Loratadine—Pharyngitis—Methotrexate—testicular cancer	0.000458	0.00249	CcSEcCtD
Loratadine—Hepatobiliary disease—Epirubicin—testicular cancer	0.000455	0.00248	CcSEcCtD
Loratadine—Epistaxis—Epirubicin—testicular cancer	0.000454	0.00247	CcSEcCtD
Loratadine—Feeling abnormal—Etoposide—testicular cancer	0.000451	0.00246	CcSEcCtD
Loratadine—Nausea—Dactinomycin—testicular cancer	0.00045	0.00245	CcSEcCtD
Loratadine—Gastrointestinal pain—Etoposide—testicular cancer	0.000448	0.00244	CcSEcCtD
Loratadine—Drowsiness—Doxorubicin—testicular cancer	0.000446	0.00242	CcSEcCtD
Loratadine—Vomiting—Ifosfamide—testicular cancer	0.000441	0.0024	CcSEcCtD
Loratadine—Rash—Ifosfamide—testicular cancer	0.000437	0.00238	CcSEcCtD
Loratadine—Dermatitis—Ifosfamide—testicular cancer	0.000437	0.00238	CcSEcCtD
Loratadine—Abdominal pain—Etoposide—testicular cancer	0.000433	0.00236	CcSEcCtD
Loratadine—Body temperature increased—Etoposide—testicular cancer	0.000433	0.00236	CcSEcCtD
Loratadine—Tinnitus—Methotrexate—testicular cancer	0.000431	0.00234	CcSEcCtD
Loratadine—Asthenia—Cisplatin—testicular cancer	0.000429	0.00233	CcSEcCtD
Loratadine—Pharyngitis—Epirubicin—testicular cancer	0.000429	0.00233	CcSEcCtD
Loratadine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000421	0.00229	CcSEcCtD
Loratadine—Epistaxis—Doxorubicin—testicular cancer	0.00042	0.00229	CcSEcCtD
Loratadine—Immune system disorder—Methotrexate—testicular cancer	0.000417	0.00227	CcSEcCtD
Loratadine—Nausea—Ifosfamide—testicular cancer	0.000412	0.00224	CcSEcCtD
Loratadine—Diarrhoea—Cisplatin—testicular cancer	0.000409	0.00223	CcSEcCtD
Loratadine—Alopecia—Methotrexate—testicular cancer	0.000408	0.00222	CcSEcCtD
Loratadine—Tinnitus—Epirubicin—testicular cancer	0.000403	0.00219	CcSEcCtD
Loratadine—Pharyngitis—Doxorubicin—testicular cancer	0.000397	0.00216	CcSEcCtD
Loratadine—Dysgeusia—Methotrexate—testicular cancer	0.000394	0.00214	CcSEcCtD
Loratadine—Asthenia—Etoposide—testicular cancer	0.000393	0.00214	CcSEcCtD
Loratadine—Immune system disorder—Epirubicin—testicular cancer	0.00039	0.00212	CcSEcCtD
Loratadine—Arrhythmia—Epirubicin—testicular cancer	0.000386	0.0021	CcSEcCtD
Loratadine—Alopecia—Epirubicin—testicular cancer	0.000382	0.00208	CcSEcCtD
Loratadine—Vomiting—Cisplatin—testicular cancer	0.00038	0.00207	CcSEcCtD
Loratadine—Rash—Cisplatin—testicular cancer	0.000377	0.00205	CcSEcCtD
Loratadine—Dermatitis—Cisplatin—testicular cancer	0.000377	0.00205	CcSEcCtD
Loratadine—Diarrhoea—Etoposide—testicular cancer	0.000375	0.00204	CcSEcCtD
Loratadine—Ill-defined disorder—Methotrexate—testicular cancer	0.000373	0.00203	CcSEcCtD
Loratadine—Tinnitus—Doxorubicin—testicular cancer	0.000373	0.00203	CcSEcCtD
Loratadine—Tension—Epirubicin—testicular cancer	0.000369	0.00201	CcSEcCtD
Loratadine—Dysgeusia—Epirubicin—testicular cancer	0.000369	0.002	CcSEcCtD
Loratadine—Nervousness—Epirubicin—testicular cancer	0.000365	0.00199	CcSEcCtD
Loratadine—Malaise—Methotrexate—testicular cancer	0.000363	0.00197	CcSEcCtD
Loratadine—Dizziness—Etoposide—testicular cancer	0.000362	0.00197	CcSEcCtD
Loratadine—Immune system disorder—Doxorubicin—testicular cancer	0.000361	0.00197	CcSEcCtD
Loratadine—Arrhythmia—Doxorubicin—testicular cancer	0.000357	0.00194	CcSEcCtD
Loratadine—Nausea—Cisplatin—testicular cancer	0.000355	0.00193	CcSEcCtD
Loratadine—Alopecia—Doxorubicin—testicular cancer	0.000353	0.00192	CcSEcCtD
Loratadine—Cough—Methotrexate—testicular cancer	0.000351	0.00191	CcSEcCtD
Loratadine—Ill-defined disorder—Epirubicin—testicular cancer	0.000349	0.0019	CcSEcCtD
Loratadine—Vomiting—Etoposide—testicular cancer	0.000348	0.00189	CcSEcCtD
Loratadine—Agitation—Epirubicin—testicular cancer	0.000346	0.00188	CcSEcCtD
Loratadine—Rash—Etoposide—testicular cancer	0.000345	0.00188	CcSEcCtD
Loratadine—Dermatitis—Etoposide—testicular cancer	0.000345	0.00188	CcSEcCtD
Loratadine—Headache—Etoposide—testicular cancer	0.000343	0.00187	CcSEcCtD
Loratadine—Chest pain—Methotrexate—testicular cancer	0.000342	0.00186	CcSEcCtD
Loratadine—Myalgia—Methotrexate—testicular cancer	0.000342	0.00186	CcSEcCtD
Loratadine—Tension—Doxorubicin—testicular cancer	0.000342	0.00186	CcSEcCtD
Loratadine—Dysgeusia—Doxorubicin—testicular cancer	0.000341	0.00185	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00034	0.00185	CcSEcCtD
Loratadine—Malaise—Epirubicin—testicular cancer	0.000339	0.00185	CcSEcCtD
Loratadine—Discomfort—Methotrexate—testicular cancer	0.000338	0.00184	CcSEcCtD
Loratadine—Nervousness—Doxorubicin—testicular cancer	0.000338	0.00184	CcSEcCtD
Loratadine—Syncope—Epirubicin—testicular cancer	0.000337	0.00184	CcSEcCtD
Loratadine—Palpitations—Epirubicin—testicular cancer	0.000333	0.00181	CcSEcCtD
Loratadine—Loss of consciousness—Epirubicin—testicular cancer	0.000331	0.0018	CcSEcCtD
Loratadine—Cough—Epirubicin—testicular cancer	0.000328	0.00179	CcSEcCtD
Loratadine—Anaphylactic shock—Methotrexate—testicular cancer	0.000328	0.00179	CcSEcCtD
Loratadine—Nausea—Etoposide—testicular cancer	0.000325	0.00177	CcSEcCtD
Loratadine—Hypertension—Epirubicin—testicular cancer	0.000325	0.00177	CcSEcCtD
Loratadine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000323	0.00176	CcSEcCtD
Loratadine—Nervous system disorder—Methotrexate—testicular cancer	0.000322	0.00175	CcSEcCtD
Loratadine—Chest pain—Epirubicin—testicular cancer	0.00032	0.00174	CcSEcCtD
Loratadine—Myalgia—Epirubicin—testicular cancer	0.00032	0.00174	CcSEcCtD
Loratadine—Agitation—Doxorubicin—testicular cancer	0.00032	0.00174	CcSEcCtD
Loratadine—Skin disorder—Methotrexate—testicular cancer	0.000319	0.00173	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000318	0.00173	CcSEcCtD
Loratadine—Discomfort—Epirubicin—testicular cancer	0.000317	0.00172	CcSEcCtD
Loratadine—Malaise—Doxorubicin—testicular cancer	0.000314	0.00171	CcSEcCtD
Loratadine—Dry mouth—Epirubicin—testicular cancer	0.000313	0.0017	CcSEcCtD
Loratadine—Syncope—Doxorubicin—testicular cancer	0.000312	0.0017	CcSEcCtD
Loratadine—Palpitations—Doxorubicin—testicular cancer	0.000308	0.00167	CcSEcCtD
Loratadine—Anaphylactic shock—Epirubicin—testicular cancer	0.000307	0.00167	CcSEcCtD
Loratadine—Hypotension—Methotrexate—testicular cancer	0.000307	0.00167	CcSEcCtD
Loratadine—Loss of consciousness—Doxorubicin—testicular cancer	0.000306	0.00166	CcSEcCtD
Loratadine—Cough—Doxorubicin—testicular cancer	0.000304	0.00165	CcSEcCtD
Loratadine—Shock—Epirubicin—testicular cancer	0.000302	0.00164	CcSEcCtD
Loratadine—Nervous system disorder—Epirubicin—testicular cancer	0.000301	0.00164	CcSEcCtD
Loratadine—Hypertension—Doxorubicin—testicular cancer	0.000301	0.00164	CcSEcCtD
Loratadine—Tachycardia—Epirubicin—testicular cancer	0.0003	0.00163	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000299	0.00163	CcSEcCtD
Loratadine—Skin disorder—Epirubicin—testicular cancer	0.000298	0.00162	CcSEcCtD
Loratadine—Insomnia—Methotrexate—testicular cancer	0.000297	0.00161	CcSEcCtD
Loratadine—Myalgia—Doxorubicin—testicular cancer	0.000296	0.00161	CcSEcCtD
Loratadine—Chest pain—Doxorubicin—testicular cancer	0.000296	0.00161	CcSEcCtD
Loratadine—Paraesthesia—Methotrexate—testicular cancer	0.000295	0.0016	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000294	0.0016	CcSEcCtD
Loratadine—Discomfort—Doxorubicin—testicular cancer	0.000293	0.00159	CcSEcCtD
Loratadine—Somnolence—Methotrexate—testicular cancer	0.000292	0.00159	CcSEcCtD
Loratadine—Dry mouth—Doxorubicin—testicular cancer	0.00029	0.00158	CcSEcCtD
Loratadine—Dyspepsia—Methotrexate—testicular cancer	0.000289	0.00157	CcSEcCtD
Loratadine—Hypotension—Epirubicin—testicular cancer	0.000287	0.00156	CcSEcCtD
Loratadine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000284	0.00155	CcSEcCtD
Loratadine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000283	0.00154	CcSEcCtD
Loratadine—Fatigue—Methotrexate—testicular cancer	0.000283	0.00154	CcSEcCtD
Loratadine—Pain—Methotrexate—testicular cancer	0.000281	0.00153	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.00028	0.00152	CcSEcCtD
Loratadine—Shock—Doxorubicin—testicular cancer	0.00028	0.00152	CcSEcCtD
Loratadine—Nervous system disorder—Doxorubicin—testicular cancer	0.000279	0.00152	CcSEcCtD
Loratadine—Insomnia—Epirubicin—testicular cancer	0.000278	0.00151	CcSEcCtD
Loratadine—Tachycardia—Doxorubicin—testicular cancer	0.000277	0.00151	CcSEcCtD
Loratadine—Skin disorder—Doxorubicin—testicular cancer	0.000276	0.0015	CcSEcCtD
Loratadine—Paraesthesia—Epirubicin—testicular cancer	0.000276	0.0015	CcSEcCtD
Loratadine—Somnolence—Epirubicin—testicular cancer	0.000273	0.00149	CcSEcCtD
Loratadine—Feeling abnormal—Methotrexate—testicular cancer	0.00027	0.00147	CcSEcCtD
Loratadine—Dyspepsia—Epirubicin—testicular cancer	0.00027	0.00147	CcSEcCtD
Loratadine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000268	0.00146	CcSEcCtD
Loratadine—Hypotension—Doxorubicin—testicular cancer	0.000266	0.00144	CcSEcCtD
Loratadine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000265	0.00144	CcSEcCtD
Loratadine—Fatigue—Epirubicin—testicular cancer	0.000265	0.00144	CcSEcCtD
Loratadine—Pain—Epirubicin—testicular cancer	0.000263	0.00143	CcSEcCtD
Loratadine—Constipation—Epirubicin—testicular cancer	0.000263	0.00143	CcSEcCtD
Loratadine—Abdominal pain—Methotrexate—testicular cancer	0.000259	0.00141	CcSEcCtD
Loratadine—Body temperature increased—Methotrexate—testicular cancer	0.000259	0.00141	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000259	0.00141	CcSEcCtD
Loratadine—Insomnia—Doxorubicin—testicular cancer	0.000257	0.0014	CcSEcCtD
Loratadine—Paraesthesia—Doxorubicin—testicular cancer	0.000255	0.00139	CcSEcCtD
Loratadine—Feeling abnormal—Epirubicin—testicular cancer	0.000253	0.00138	CcSEcCtD
Loratadine—Somnolence—Doxorubicin—testicular cancer	0.000253	0.00137	CcSEcCtD
Loratadine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000251	0.00137	CcSEcCtD
Loratadine—Dyspepsia—Doxorubicin—testicular cancer	0.00025	0.00136	CcSEcCtD
Loratadine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000245	0.00133	CcSEcCtD
Loratadine—Fatigue—Doxorubicin—testicular cancer	0.000245	0.00133	CcSEcCtD
Loratadine—Pain—Doxorubicin—testicular cancer	0.000243	0.00132	CcSEcCtD
Loratadine—Constipation—Doxorubicin—testicular cancer	0.000243	0.00132	CcSEcCtD
Loratadine—Abdominal pain—Epirubicin—testicular cancer	0.000243	0.00132	CcSEcCtD
Loratadine—Body temperature increased—Epirubicin—testicular cancer	0.000243	0.00132	CcSEcCtD
Loratadine—Asthenia—Methotrexate—testicular cancer	0.000235	0.00128	CcSEcCtD
Loratadine—Feeling abnormal—Doxorubicin—testicular cancer	0.000234	0.00127	CcSEcCtD
Loratadine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000232	0.00126	CcSEcCtD
Loratadine—Body temperature increased—Doxorubicin—testicular cancer	0.000225	0.00122	CcSEcCtD
Loratadine—Abdominal pain—Doxorubicin—testicular cancer	0.000225	0.00122	CcSEcCtD
Loratadine—Diarrhoea—Methotrexate—testicular cancer	0.000225	0.00122	CcSEcCtD
Loratadine—Asthenia—Epirubicin—testicular cancer	0.00022	0.0012	CcSEcCtD
Loratadine—Dizziness—Methotrexate—testicular cancer	0.000217	0.00118	CcSEcCtD
Loratadine—Diarrhoea—Epirubicin—testicular cancer	0.00021	0.00114	CcSEcCtD
Loratadine—Vomiting—Methotrexate—testicular cancer	0.000209	0.00113	CcSEcCtD
Loratadine—Rash—Methotrexate—testicular cancer	0.000207	0.00113	CcSEcCtD
Loratadine—Dermatitis—Methotrexate—testicular cancer	0.000207	0.00112	CcSEcCtD
Loratadine—Headache—Methotrexate—testicular cancer	0.000206	0.00112	CcSEcCtD
Loratadine—Asthenia—Doxorubicin—testicular cancer	0.000204	0.00111	CcSEcCtD
Loratadine—Dizziness—Epirubicin—testicular cancer	0.000203	0.0011	CcSEcCtD
Loratadine—Vomiting—Epirubicin—testicular cancer	0.000195	0.00106	CcSEcCtD
Loratadine—Nausea—Methotrexate—testicular cancer	0.000195	0.00106	CcSEcCtD
Loratadine—Diarrhoea—Doxorubicin—testicular cancer	0.000194	0.00106	CcSEcCtD
Loratadine—Rash—Epirubicin—testicular cancer	0.000194	0.00105	CcSEcCtD
Loratadine—Dermatitis—Epirubicin—testicular cancer	0.000193	0.00105	CcSEcCtD
Loratadine—Headache—Epirubicin—testicular cancer	0.000192	0.00105	CcSEcCtD
Loratadine—Dizziness—Doxorubicin—testicular cancer	0.000188	0.00102	CcSEcCtD
Loratadine—Nausea—Epirubicin—testicular cancer	0.000182	0.000992	CcSEcCtD
Loratadine—Vomiting—Doxorubicin—testicular cancer	0.000181	0.000983	CcSEcCtD
Loratadine—Rash—Doxorubicin—testicular cancer	0.000179	0.000975	CcSEcCtD
Loratadine—Dermatitis—Doxorubicin—testicular cancer	0.000179	0.000974	CcSEcCtD
Loratadine—Headache—Doxorubicin—testicular cancer	0.000178	0.000968	CcSEcCtD
Loratadine—Nausea—Doxorubicin—testicular cancer	0.000169	0.000918	CcSEcCtD
